FDA-approved drug may block resistance to anti-angiogenesis therapy
General study identifies targetable pathway that induces immunosuppressive environment in colorectal cancer...
List view / Grid view
News
Type 2 diabetes drug provides significant benefits to type 1 diabetic patients
A study has found that a majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels...
New microchip technology could be used to track ‘smart pills’
Researchers have developed microscale devices that relay their location in the body...
BC Platforms launches global genomics and clinical data analytics resource
A world leader in genomic data has launched BC|RQUEST, a unique resource that enables integrated analytics of genomic and clinical data...
Magnetic cellular ‘Legos’ for the regenerative medicine of the future
By incorporating magnetic nanoparticles in cells researchers have succeeded in creating cellular magnetic "Legos."...
Cancer drug stimulates tripolar mode of mitosis
Taxanes inhibit cell division and make cancer cells sensitive to radiation therapy, a current study has investigated the underlying mechanisms of this action...
Nivolumab superior to ipilimumab for adjuvant treatment of melanoma
Adjuvant nivolumab has been found to be more superior than ipilimumab in the standard of care in patients with surgically resected stage III/IV melanoma...
Paul Royall joins European Pharmaceutical Review
Dr Paul Royall, Senior Lecturer in Pharmaceutics at King’s College London, and Programme Director of the MSc in Pharmaceutical Analysis and Quality Control, has joined European Pharmaceutical Review's Editorial Advisory Board.
Merck joins forces to pioneer global oncology big data initiative
Merck has announced that it will enter into a strategic collaboration with Project Data Sphere LLC, for oncology innovations...
Tecan introduces new solution for walkaway LC-MS sample prep
Tecan has unveiled its latest innovation, the automated RESOLVEX™ A200 positive pressure workstation for LC-MS sample prep...
Taselisib boosts breast tumour shrinkage
According to results of the LORELEI clinical trial, adding taselisib to letrozole before surgery significantly improved outcomes for patients with early breast cancer...
Prestigious scientific organisations support Lab Innovations
Lab Innovations – the UK’s only dedicated showcase for laboratory, analytical and biotech equipment – continues to garner support from across the scientific community...
Ingenza invests in faster fermentation development
Leading industrial biotechnology company Ingenza has acquired a high performance benchtop bioreactor system to enable faster development of new fermentation processes...
NewAge® Industries Achieves Landfill-Free Status
All waste is recycled or used in energy recovery systems...
Nivolumab cuts relapse by one third compared to Ipilimumab
Alternative immunotherapy drug nivolumab is more effective than current standard of care in treating advanced melanoma after surgical removal of disease.
